Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures
Abstract Computational oncology advances multi-targeted therapies for Colon Cancer (CC) by leveraging molecular data and identifying potential drug candidates. However, challenges persist in understanding CC molecular pathways and identifying essential genes. This research integrates biomarker signa...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-01058-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|